Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study
Nabil Seery, Robb Wesselingh, Paul Beech, James Broadley, Sarah Griffith, Tiffany Rushen, James Beharry, Caleb Tan, Noushin Chiniforoush, Laurie McLaughlin, Liora Ter Horst, Mirasol Forcadela, Tracie Tan, Christina Kazzi, Cassie Nesbitt, Katherine Buzzard, Andrew Duncan, Amy Halliday, Wendyl D'Souza, Yang Tran, Anneke Van Der Walt, Genevieve Skinner, Andrew Swayne, Charles B Malpas, Amy Brodtmann, David Gillis, Bruce Taylor, Ernest G Butler, Tomas Kalincik, Udaya Seneviratne, Richard Macdonell, Stefan Blum, Sudarshini Ramanathan, Stephen W Reddel, Todd A Hardy, Terence J O'Brien, Paul Sanfilippo, Helmut Butzkueven, Mastura Monif, Australian Autoimmune Encephalitis Consortium
J Neurol. 2025 Apr 25;272(5):361. doi: 10.1007/s00415-025-13069-1.

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Dana Horakova, Bianca Weinstock-Guttman, Vahid Shaygannejad, Masoud Etemadifar, Raed Alroughani, Francesco Patti, Sara Eichau, Alexandre Prat, Alessandra Lugaresi, Valentina Tomassini, Allan G Kermode, Maria Pia Amato, Recai Turkoglu, Ayse Altintas, Katherine Buzzard, Aysun Soysal, Anneke van der Walt, Helmut Butzkueven, Yolanda Blanco, Oliver Gerlach, Samia J Khoury, Michael Barnett, Nevin John, Jeannette Lechner-Scott, Matteo Foschi, Andrea Surcinelli, Vincent van Pesch, Julie Prevost, Maria Jose Sa, Davide Maimone, Marie D'hooghe, Stella Hughes, Suzanne Hodgkinson, Chris McGuigan, Elisabetta Cartechini, Bruce Taylor, Daniele Spitaleri, Mark Slee, Pamela McCombe, Bassem Yamout, Pascal Benkert, Jens Kuhle, Ludwig Kappos, Izanne Roos, Tomas Kalincik, MSBase Study Group, Eva Kubala Havrdova, Marc Girard, Pierre Duquette, Marzena Fabis-Pedrini, William M Carroll, Olga Skibina, Riadh Gouider, Saloua Mrabet, Cristina Ramo-Tello, Claudio Solaro, Mario Habek, Bart Van Wijmeersch, Radek Ampapa, Richard Macdonell, Celia Oreja-Guevara, Koen de Gans, Guy Laureys, Jiwon Oh, Justin Garber, Orla Gray, Eduardo Agüera-Morales, Jose Luis Sanchez-Menoyo, Tamara Castillo-Triviño, Nikolaos Grigoriadis, Thor Petersen, Todd A Hardy, Steve Vucic, Stephen Reddel, Sudarshini Ramanathan, Abdullah Al-Asmi, Mihaela Simu, Seyed Mohammad Baghbanian, Dieter Poehlau, Talal Al-Harbi, Juan Ignacio Rojas, Norma Deri, Patrice Lalive, Melissa Cambron, Tunde Csepany, Neil Shuey, Barbara Willekens, Cameron Shaw, Danny Decoo, Jennifer Massey, Özgür Yaldizli, Tobias Derfuss, Cristina Granziera
JAMA Neurol. 2025 Apr 14:e250495. doi: 10.1001/jamaneurol.2025.0495. Online ahead of print.

Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study
Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, Paul Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia J Khoury, Tunde Csepany, Barbara Willekens, Masoud Etemadifar, Serkan Ozakbas, Petra Nytrova, Ayse Altintas, Abdullah Al-Asmi, Cristina Ramo-Tello, Guy Laureys, Francesco Patti, Dana Horakova, Matteo Foschi, Cavit Boz, Pamela McCombe, Recai Turkoglu, Izanne Roos, Jeannette Lechner-Scott, Tomas Kalincik, Vilija Jokubaitis, Helmut Butzkueven, Mastura Monif
J Neurol. 2025 Apr 14;272(5):339. doi: 10.1007/s00415-025-13064-6.

Recommendations for essential medicines for multiple sclerosis in low-resource settings
Deanna Saylor, Nick Rijke, Jennifer McDonell, Joanna Laurson-Doube, Jagannadha Avasarala, Elisa Baldin, Tapas K Banerjee, Ivana Bogdanovic, Riley Bove, D K Chawla, Kathleen Costello, Cinzia Del Giovane, Najoua El Abkari, Graziella Filippini, Matteo Foschi, Marien Gonzalez-Lorenzo, Anne Helme, Dina Jacobs, Tomas Kalincik, Aukje Mantel-Teeuwisse, Silvia Minozzi, Carlos Navas, Francesco Nonino, Oluwadamilola O Ojo, Bianca Ozcan, Elisabetta Pasi, Guy Peryer, Andrea Prato Chichiraldi, Ben Ridley, Dilraj S Sokhi, Anthony Traboulsee, Irene Tramacere, Janis Sn Tye, Simona Vecchi, Shanthi Viswanathan, Feng Xie, Maya Zeineddine, Holger Schunemann, Thomas Piggott
Mult Scler. 2025 Apr;31(4):464-473. doi: 10.1177/13524585241308134. Epub 2024 Dec 31.

Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis
Daniel Merlo, Johnson Ja, Yi Chao Foong, Chao Zhu, Melissa Gresle, Tomas Kalincik, Jeannette Lechner-Scott, Trevor Kilpatrick, Michael Barnett, Bruce Taylor, Katherine Buzzard, David Darby, Helmut Butzkueven, Anneke van der Walt
Mult Scler. 2025 Apr;31(5):595-606. doi: 10.1177/13524585251329035. Epub 2025 Apr 1.

Efficacy of natalizumab in secondary progressive multiple sclerosis: analysis of two phase III trials
Winston Dzau, Izanne Roos, Tomas Kalincik
J Neurol Neurosurg Psychiatry. 2025 Mar 6:jnnp-2024-335495. doi: 10.1136/jnnp-2024-335495. Online ahead of print.

Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner-Scott, Michael Barnett, Chenyu Wang, Bruce V Taylor, Tomas Kalincik, Trevor Kilpatrick, David Darby, Pamela Dobay, Johan van Beek, Robert Hyde, Steve Simpson-Yap, Helmut Butzkueven, Anneke van der Walt
Ann Clin Transl Neurol. 2025 Apr;12(4):842-850. doi: 10.1002/acn3.70015. Epub 2025 Feb 25.

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
Simona Toscano, Tim Spelman, Serkan Ozakbas, Raed Alroughani, Clara G Chisari, Salvatore Lo Fermo, Alexandre Prat, Marc Girard, Pierre Duquette, Guillermo Izquierdo, Sara Eichau, Pierre Grammond, Cavit Boz, Tomas Kalincik, Yolanda Blanco, Katherine Buzzard, Olga Skibina, Maria Jose Sa, Anneke van der Walt, Helmut Butzkueven, Murat Terzi, Oliver Gerlach, Francois Grand'Maison, Matteo Foschi, Andrea Surcinelli, Michael Barnett, Alessandra Lugaresi, Marco Onofrj, Bassem Yamout, Samia J Khoury, Julie Prevost, Jeannette Lechner-Scott, Davide Maimone, Maria Pia Amato, Daniele Spitaleri, Vincent Van Pesch, Richard Macdonell, Elisabetta Cartechini, Koen de Gans, Mark Slee, Tamara Castillo-Triviño, Aysun Soysal, Jose Luis Sanchez-Menoyo, Guy Laureys, Liesbeth Van Hijfte, Pamela McCombe, Ayse Altintas, Bianca Weinstock-Guttman, Eduardo Aguera-Morales, Masoud Etemadifar, Cristina Ramo-Tello, Nevin John, Recai Turkoglu, Suzanne Hodgkinson, Sarah Besora, Bart Van Wijmeersch, Ricardo Fernandez-Bolaños, Francesco Patti, MSBase Study Group
Neurotherapeutics. 2025 Mar;22(2):e00552. doi: 10.1016/j.neurot.2025.e00552. Epub 2025 Feb 17.

Explainable time-to-progression predictions in multiple sclerosis
Robbe D'hondt, Klest Dedja, Sofie Aerts, Bart Van Wijmeersch, Tomas Kalincik, Stephen Reddel, Eva Kubala Havrdova, Alessandra Lugaresi, Bianca Weinstock-Guttman, Saloua Mrabet, Patrice Lalive, Allan G Kermode, Serkan Ozakbas, Francesco Patti, Alexandre Prat, Valentina Tomassini, Izanne Roos, Raed Alroughani, Oliver Gerlach, Samia J Khoury, Vincent van Pesch, Maria José Sá, Julie Prevost, Daniele Spitaleri, Pamela McCombe, Claudio Solaro, Anneke van der Walt, Helmut Butzkueven, Guy Laureys, José Luis Sánchez-Menoyo, Koen de Gans, Abdullah Al-Asmi, Norma Deri, Tunde Csepany, Talal Al-Harbi, William M Carroll, Csilla Rozsa, Bhim Singhal, Todd A Hardy, Sudarshini Ramanathan, Liesbet Peeters, Celine Vens, MSBase Study Group
Comput Methods Programs Biomed. 2025 May;263:108624. doi: 10.1016/j.cmpb.2025.108624. Epub 2025 Feb 6.

Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Dana Horakova, Eva Kubala Havrdova, Sara Eichau, Francesco Patti, Pierre Grammond, Katherine Buzzard, Olga Skibina, Alexandre Prat, Marc Girard, Francois Grand'Maison, Raed Alroughani, Jeannette Lechner-Scott, Daniele Spitaleri, Michael Barnett, Elisabetta Cartechini, Maria Jose Sa, Oliver Gerlach, Anneke van der Walt, Helmut Butzkueven, Julie Prevost, Tamara Castillo-Triviño, Bassem Yamout, Samia J Khoury, Özgür Yaldizli, Tobias Derfuss, Cristina Granziera, Jens Kuhle, Ludwig Kappos, Izanne Roos, Tomas Kalincik, MSBase Study Group
CNS Drugs. 2025 Apr;39(4):403-416. doi: 10.1007/s40263-025-01164-w. Epub 2025 Feb 14.

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2
Jessica Shipley, James Beharry, Wei Yeh, Nabil Seery, Yi Chao Foong, Darshini Ayton, Pakeeran Siriratnam, Tracie Tan, Heidi Beadnall, Joshua Barton, Francesca Bridge, Robb Wesselingh, Lisa Taylor, Louise Rath, Jodi Haartsen, Mohammad Gadi, Cassie Nesbitt, Michael Zhong, Victoria Cushing, Fiona McKay, Julia Morahan, Benjamin Peter Trewin, Izanne Roos, Mark Marriott, Ai-Lan Nguyen, Emma Downey, Joanne Crosby, Julian Bosco, Jennifer Taylor, Lauren Giles, Nevin John, Ernest Butler, Anneke van der Walt, Helmut Butzkueven, Stefan Blum, Marion Simpson, Mark Slee, Sudarshini Ramanathan, Todd Hardy, Richard A L Macdonell, Katherine Buzzard, Deborah F Mason, Jeannette Lechner-Scott, Trevor J Kilpatrick, Tomas Kalincik, Bruce V Taylor, Simon A Broadley, Stephen Reddel, Douglas Johnson, Mastura Monif, MS Interest Group, Australian and New Zealand Association of Neurologists
Med J Aust. 2025 Apr 21;222(7):365-371. doi: 10.5694/mja2.52577. Epub 2025 Feb 9.

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1
Jessica Shipley, James Beharry, Wei Yeh, Nabil Seery, Yi Chao Foong, Darshini Ayton, Pakeeran Siriratnam, Tracie Tan, Heidi Beadnall, Joshua Barton, Francesca Bridge, Robb Wesselingh, Lisa Taylor, Louise Rath, Jodi Haartsen, Mohammad Gadi, Cassie Nesbitt, Michael Zhong, Victoria Cushing, Fiona McKay, Julia Morahan, Benjamin Peter Trewin, Izanne Roos, Mark Marriott, Ai-Lan Nguyen, Emma Downey, Joanne Crosby, Julian Bosco, Jennifer Taylor, Lauren Giles, Nevin John, Ernest Butler, Anneke van der Walt, Helmut Butzkueven, Stefan Blum, Marion Simpson, Mark Slee, Sudarshini Ramanathan, Todd Hardy, Richard A L Macdonell, Katherine Buzzard, Deborah F Mason, Jeannette Lechner-Scott, Trevor J Kilpatrick, Tomas Kalincik, Bruce V Taylor, Simon A Broadley, Stephen Reddel, Douglas Johnson, Mastura Monif, MS Interest Group, Australian and New Zealand Association of Neurologists
Med J Aust. 2025 Apr 21;222(7):356-364. doi: 10.5694/mja2.52578. Epub 2025 Feb 9.

Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications
Julie A Campbell, Glen J Henson, Valery Fuh Ngwa, Hasnat Ahmad, Bruce V Taylor, Ingrid van der Mei, MSBase Australian Researchers, Andrew J Palmer
Pharmacoeconomics. 2025 Feb;43(2):241. doi: 10.1007/s40273-024-01461-0.

Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner-Scott, Michael Barnett, Bruce V Taylor, Tomas Kalincik, Trevor Kilpatrick, David Darby, Pamela Dobay, Johan van Beek, Robert Hyde, Steve Simpson-Yap, Helmut Butzkueven, Anneke van der Walt
Eur J Neurol. 2025 Jan;32(1):e70000. doi: 10.1111/ene.70000.

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort
Dhamidhu Eratne, Qiao-Xin Li, Courtney Lewis, Christa Dang, Matthew J Y Kang, Jasleen Grewal, Samantha Loi, Mark Walterfang, Andrew H Evans, Charles B Malpas, Steve Pedrini, Ralph Martins, Pratishtha Chatterjee, Henrik Zetterberg, Kaj Blennow, Samuel F Berkovic, Alexander F Santillo, Steven Collins, Colin L Masters, Dennis Velakoulis, MiND Study Group
J Neurol. 2024 Dec 12;272(1):25. doi: 10.1007/s00415-024-12732-3.

Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, Pascal Benkert, Sandra Vukusic, Maria Trojano, Jan Hillert, Anna Glaser, Robert Hyde, Tim Spelman, Melinda Magyari, Frederik Elberling, Luigi Pontieri, Nils Koch-Henriksen, Per Soelberg Sørensen, Oliver Gerlach, Alexandre Prat, Marc Girard, Sara Eichau, Pierre Grammond, Dana Horakova, Cristina Ramo-Tello, Izanne Roos, Katherine Buzzard, Jeanette Lechner Scott, José Luis Sánchez-Menoyo, Raed Alroughani, Julie Prévost, Jens Kuhle, Orla Gray, Guillaume Mathey, Laure Michel, Jonathan Ciron, Jérôme De Sèze, Elisabeth Maillart, Aurelie Ruet, Pierre Labauge, Helene Zephir, Arnaud Kwiatkowski, Anneke van der Walt, Tomas Kalincik, Helmut Butzkueven, Italian MS Register, Observatoire Français de la Sclérose en Plaques (OFSEP), MSBase Study Group, Swedish MS Registry, Big MS Data Network
J Neurol Neurosurg Psychiatry. 2024 Dec 6:jnnp-2024-334700. doi: 10.1136/jnnp-2024-334700. Online ahead of print.

Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD
Pakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, Paul G Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Z Yeh, Chao Zhu, Samia J Khoury, Tunde Csepany, Barbara Willekens, Masoud Etemadifar, Serkan Ozakbas, Petra Nytrova, Ayse Altintas, Abdullah Al-Asmi, Cristina M Ramo-Tello, Guy Laureys, Francesco Patti, Dana Horakova, Matteo Foschi, Cavit Boz, Pamela A Mccombe, Recai Turkoglu, Jeannette Lechner-Scott, Izanne Roos, Tomas Kalincik, Vilija G Jokubaitis, Helmut Butzkueven, Mastura Monif, for MSBase
Neurology. 2024 Dec 24;103(12):e209940. doi: 10.1212/WNL.0000000000209940. Epub 2024 Nov 19.

Utility of icobrain for brain volumetry in multiple sclerosis clinical practice
Ai-Lan Nguyen, Maria Pia Sormani, Dana Horakova, Eva H Havrdova, Michael H Barnett, Nicola De Stefano, Marco Battaglini, Manuela Vaneckova, Elaine Lui, Frank Gaillard, Patricia M Desmond, Hayden Prime, Mineesh Datta, Anneke Van der Walt, Vilija G Jokubaitis, Femke Podevyn, Robert Zivadinov, Bianca Weinstock-Guttman, Marie B D'hooghe, Guy Nagels, Vincent Van Pesch, Guy Laureys, Liesbeth Van Hijfte, Jeannette Lechner-Scott, Francesco Patti, Edgardo Cristiano, Juan I Rojas, Diana M Sima, Wim Van Hecke, Tomas Kalincik, Helmut Butzkueven
Mult Scler Relat Disord. 2024 Dec;92:106148. doi: 10.1016/j.msard.2024.106148. Epub 2024 Nov 8.

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study
David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, Raed Alroughani, Cavit Boz, Murat Terzi, Tomas Kalincik, Yolanda Blanco, Matteo Foschi, Andrea Surcinelli, Katherine Buzzard, Olga Skibina, Guy Laureys, Liesbeth Van Hijfte, Cristina Ramo-Tello, Aysun Soysal, Jose Luis Sanchez-Menoyo, Mario Habek, Elisabetta Cartechini, Juan Ignacio Rojas, Rana Karabudak, Barbara Willekens, Talal Al-Harbi, Yara Fragoso, Tamara Castillo-Triviño, Danny Decoo, Maria Cecilia Aragon de Vecino, Eli Skromne, Carmen-Adella Sirbu, Chao Zhu, Daniel Merlo, Melissa Gresle, Helmut Butzkueven, Anneke Van Der Walt
Ther Adv Neurol Disord. 2024 Nov 7;17:17562864241278496. doi: 10.1177/17562864241278496. eCollection 2024.

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
Wei Z Yeh, Anneke Van Der Walt, Olga G Skibina, Tomas Kalincik, Raed Alroughani, Allan G Kermode, Marzena J Fabis-Pedrini, William M Carroll, Jeannette Lechner-Scott, Cavit Boz, Serkan Ozakbas, Katherine Buzzard, Mario Habek, Nevin A John, Alexandre Prat, Marc Girard, Pierre Duquette, Seyed Mohammad Baghbanian, Suzanne Hodgkinson, Vincent Van Pesch, Guy Laureys, Barbara Willekens, Julie Prevost, Matteo Foschi, Koen De Gans, Dana Horakova, Eva Kubala Havrdova, Rana Karabudak, Francesco Patti, Pamela A Mccombe, Davide Maimone, Ayse Altintas, Radek Ampapa, Daniele Spitaleri, Oliver H H Gerlach, Maria Jose Sa, Stella Hughes, Riadh Gouider, Saloua Mrabet, Richard A Macdonell, Recai Turkoglu, Elisabetta Cartechini, Abdullah Al-Asmi, Aysun Soysal, Jiwon Oh, Erwan Muros-Le Rouzic, Sabrina Guye, Noemi Pasquarelli, Helmut Butzkueven, Vilija G Jokubaitis, MSBase Study Group
Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200328. doi: 10.1212/NXI.0000000000200328. Epub 2024 Oct 23.

Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey
Jodie I Roberts, Aravind Ganesh, Luca Bartolini, Tomas Kalincik
Neurol Clin Pract. 2025 Feb;15(1):e200376. doi: 10.1212/CPJ.0000000000200376. Epub 2024 Oct 9.

Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting
Dhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, Christa Dang, Charles B Malpas, Michael Keem, Jasleen Grewal, Vladimir Marinov, Amy Coe, Cath Kaylor-Hughes, Thomas Borchard, Chhoa Keng-Hong, Alexandra Waxmann, Burcu Saglam, Tomas Kalincik, Richard Kanaan, Wendy Kelso, Andrew Evans, Sarah Farrand, Samantha Loi, Mark Walterfang, Christiane Stehmann, Qiao-Xin Li, Steven Collins, Colin L Masters, Alexander F Santillo, Henrik Zetterberg, Kaj Blennow, Samuel F Berkovic, Dennis Velakoulis, MiND Study Group
Alzheimers Dement. 2024 Nov;20(11):7989-8001. doi: 10.1002/alz.14278. Epub 2024 Oct 6.

Neuropsychological outcomes of patients with haematological malignancies undergoing chimeric antigen receptor T-cell therapy: protocol for a prospective study
Valeriya Kuznetsova, Harsh Oza, Hannah Rosenfeld, Carmela Sales, Samantha van der Linde, Izanne Roos, Stefanie Roberts, Fiore D'Aprano, Samantha M Loi, Mark Dowling, Michael Dickinson, Tomas Kalincik, Simon J Harrison, Mary Ann Anderson, Charles B Malpas
BMJ Neurol Open. 2024 Aug 22;6(2):e000800. doi: 10.1136/bmjno-2024-000800. eCollection 2024.

Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study
Daniel Kreiter, Tomas Kalincik, Raymond Hupperts, Francesco Patti, Daniele Spitaleri, Matteo Foschi, Andrea Surcinelli, Davide Maimone, Bassem Yamout, Samia J Khoury, Jeannette Lechner-Scott, Serkan Ozakbas, Oliver Gerlach, MSBase Study Group
CNS Drugs. 2024 Nov;38(11):921-930. doi: 10.1007/s40263-024-01115-x. Epub 2024 Sep 6.

A personalized approach for anti-CD20 therapies in multiple sclerosis
Laura Hogenboom, Zoé L E van Kempen, Tomas Kalincik, Amit Bar-Or, Joep Killestein
Mult Scler Relat Disord. 2024 Nov;91:105851. doi: 10.1016/j.msard.2024.105851. Epub 2024 Aug 31.

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, Masoud Etemadifar, Serkan Ozakbas, Petra Nytrova, Ayse Altintas, Abdullah Al-Asmi, Bassem Yamout, Guy Laureys, Francesco Patti, Magdolna Simo, Andrea Surcinelli, Matteo Foschi, Pamela A McCombe, Raed Alroughani, José Luis Sánchez-Menoyo, Recai Turkoglu, Aysun Soysal, Jeanette Lechner Scott, Tomas Kalincik, Helmut Butzkueven, Vilija Jokubaitis, Saif Huda, Mastura Monif, MSBASE study group
J Neurol Neurosurg Psychiatry. 2025 Mar 24;96(4):361-369. doi: 10.1136/jnnp-2024-334090.

The era of harmonised disability outcomes in multiple sclerosis
Tomas Kalincik
Mult Scler. 2024 Aug;30(9):1091-1092. doi: 10.1177/13524585241266517. Epub 2024 Aug 14.

Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021
Steve Simpson-Yap, Vicki E Maltby, Stacey Hall, Sophia Ward, Rodney Lea, Mike Boggild, Tomas Kalincik, Cameron Shaw, Bruce Taylor, Anneke van der Walt, Jeannette Lechner-Scott
Mult Scler Relat Disord. 2024 Oct;90:105786. doi: 10.1016/j.msard.2024.105786. Epub 2024 Jul 23.

Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications
Julie A Campbell, Glen J Henson, Valery Fuh Ngwa, Hasnat Ahmad, Bruce V Taylor, Ingrid van der Mei, MSBase Australian Researchers, Andrew J Palmer
Pharmacoeconomics. 2025 Feb;43(2):223-239. doi: 10.1007/s40273-024-01417-4. Epub 2024 Aug 2.

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, Helmut Butzkueven, Katherine Buzzard, Olga Skibina, Matteo Foschi, Francois Grand'Maison, Nevin John, Pierre Grammond, Murat Terzi, Julie Prévost, Michael Barnett, Guy Laureys, Liesbeth Van Hijfte, Jose Luis Sanchez-Menoyo, Yolanda Blanco, Jiwon Oh, Pamela McCombe, Cristina Ramo Tello, Aysun Soysal, Alexandre Prat, Pierre Duquette, Bassem I Yamout, Samia Khoury, Vincent van Pesch, Richard Macdonell, Maria José Sá, Mark Slee, Jens Kuhle, Davide Maimone, Daniele LA Spitaleri, Barbara Willekens, Abdallah Al Asmi, Emma Tallantyre, Neil P Robertson, Alasdair Coles, J William L Brown, Tomas Kalincik
Mult Scler. 2024 Aug;30(9):1163-1175. doi: 10.1177/13524585241267211. Epub 2024 Aug 1.

The clinical relevance of MOG antibody testing in cerebrospinal fluid
Molly Reynolds, Irene Tan, Kristy Nguyen, Vera Merheb, Fiona X Z Lee, Benjamin P Trewin, Magdalena Lerch, Snehal Shah, Nigel Wolfe, Katherine Buzzard, Jeannette Lechner-Scott, Marzena Fabis-Pedrini, Anthony Fok, Nevin John, Chris Kneebone, Con Yiannikas, David A Brown, Allan G Kermode, Stephen Reddel, Russell C Dale, Fabienne Brilot, Sudarshini Ramanathan, Australasian MOGAD Study Group
Ann Clin Transl Neurol. 2024 Sep;11(9):2514-2519. doi: 10.1002/acn3.52163. Epub 2024 Jul 28.

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study
Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Cathérine Dekeyser, Guy Laureys, Bart Van Wijmeersch, Veronica Popescu, Tom Dhaene, Dirk Deschrijver, Willem Waegeman, Bernard De Baets, Michiel Stock, Dana Horakova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Pierre Grammond, Tomas Kalincik, Raed Alroughani, Francois Grand'Maison, Olga Skibina, Murat Terzi, Jeannette Lechner-Scott, Oliver Gerlach, Samia J Khoury, Elisabetta Cartechini, Vincent Van Pesch, Maria José Sà, Bianca Weinstock-Guttman, Yolanda Blanco, Radek Ampapa, Daniele Spitaleri, Claudio Solaro, Davide Maimone, Aysun Soysal, Gerardo Iuliano, Riadh Gouider, Tamara Castillo-Triviño, José Luis Sánchez-Menoyo, Guy Laureys, Anneke van der Walt, Jiwon Oh, Eduardo Aguera-Morales, Ayse Altintas, Abdullah Al-Asmi, Koen de Gans, Yara Fragoso, Tunde Csepany, Suzanne Hodgkinson, Norma Deri, Talal Al-Harbi, Bruce Taylor, Orla Gray, Patrice Lalive, Csilla Rozsa, Chris McGuigan, Allan Kermode, Angel Pérez Sempere, Simu Mihaela, Magdolna Simo, Todd Hardy, Danny Decoo, Stella Hughes, Nikolaos Grigoriadis, Attila Sas, Norbert Vella, Yves Moreau, Liesbet Peeters
PLOS Digit Health. 2024 Jul 25;3(7):e0000533. doi: 10.1371/journal.pdig.0000533. eCollection 2024 Jul.

CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study
Mastura Monif, Richard P Sequeira, Andrea Muscat, Sian Stuckey, Paul G Sanfilippo, Viet Minh, Naomi Loftus, Veronica Voo, Katherine Fazzolari, Melinda Moss, Vicki E Maltby, Ai-Lan Nguyen, Robb Wesselingh, Nabil Seery, Cassie Nesbitt, Josephine Baker, Chris Dwyer, Lisa Taylor, Louise Rath, Anneke Van der Walt, Mark Marriott, Tomas Kalincik, Jeannette Lechner-Scott, Terence J O'Brien, Helmut Butzkueven
Clin Immunol. 2024 Aug;265:110304. doi: 10.1016/j.clim.2024.110304. Epub 2024 Jul 2.

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka P Lal, Yi Chao Foong, Paul G Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, Izanne Roos, Jeannette Lechner-Scott, Nevin John, Aysun Soysal, Emanuele D'Amico, Riadh Gouider, Saloua Mrabet, Katrin Gross-Paju, Simón Cárdenas-Robledo, Abdorreza Naser Moghadasi, Maria Jose Sa, Orla Gray, Jiwon Oh, Stephen Reddel, Sudarshini Ramanathan, Talal Al-Harbi, Ayse Altintas, Todd A Hardy, Serkan Ozakbas, Raed Alroughani, Allan G Kermode, Andrea Surcinelli, Guy Laureys, Sara Eichau, Alexandre Prat, Marc Girard, Pierre Duquette, Suzanne Hodgkinson, Cristina Ramo-Tello, Davide Maimone, Pamela McCombe, Daniele Spitaleri, Jose Luis Sanchez-Menoyo, Mehmet Fatih Yetkin, Seyed Mohammad Baghbanian, Rana Karabudak, Abdullah Al-Asmi, Gregor Brecl Jakob, Samia J Khoury, Masoud Etemadifar, Vincent van Pesch, Katherine Buzzard, Bruce Taylor, Helmut Butzkueven, Anneke Van der Walt
J Neurol. 2024 Sep;271(9):5813-5824. doi: 10.1007/s00415-024-12518-7. Epub 2024 Jun 27.

Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms
Sarah P Griffith, Robb Wesselingh, Nabil Seery, Tiffany Rushen, Chris Kyndt, Brian Long, Udaya Seneviratne, Tomas Kalincik, Katherine Buzzard, Helmut Butzkueven, Terence J O'Brien, Rubina Alpitsis, Charles B Malpas, Mastura Monif, Australian Autoimmune Encephalitis Consortium
J Neurol. 2024 Aug;271(8):5610-5621. doi: 10.1007/s00415-024-12520-z. Epub 2024 Jun 25.

Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
Benjamin P Trewin, Russell C Dale, Jessica Qiu, Melissa Chu, Niroshan Jeyakumar, Fionna Dela Cruz, Jane Andersen, Pakeeran Siriratnam, Kit Kwan M Ma, Todd A Hardy, Anneke van der Walt, Jeanette Lechner-Scott, Helmut Butzkueven, Simon A Broadley, Michael H Barnett, Stephen W Reddel, Fabienne Brilot, Tomas Kalincik, Sudarshini Ramanathan, Australasian MOGAD Study Group
J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1054-1063. doi: 10.1136/jnnp-2024-333463.

Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis
Jannis Müller, Izanne Roos, Tomas Kalincik, Johannes Lorscheider, Edoardo Galli, Pascal Benkert, Sabine Schädelin, Sifat Sharmin, Maximilian Einsiedler, Peter Hänni, Jürg Schmid, Jens Kuhle, Tobias Derfuss, Cristina Granziera, Tjalf Ziemssen, Timo Siepmann, Özgür Yaldizli
Brain Behav. 2024 May;14(5):e3498. doi: 10.1002/brb3.3498.

Postural behaviour in people with multiple sclerosis: A complexity paradox
L Eduardo Cofré Lizama, Maya G Panisset, Liuhua Peng, Ying Tan, Tomas Kalincik, Mary P Galea
Gait Posture. 2024 Jun;111:14-21. doi: 10.1016/j.gaitpost.2024.03.013. Epub 2024 Mar 27.

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Cathérine Dekeyser, Matthias Hautekeete, Melissa Cambron, Vincent Van Pesch, Francesco Patti, Jens Kuhle, Samia Khoury, Jeanette Lechner Scott, Oliver Gerlach, Alessandra Lugaresi, Davide Maimone, Andrea Surcinelli, Pierre Grammond, Tomas Kalincik, Mario Habek, Barbara Willekens, Richard Macdonell, Patrice Lalive, Tunde Csepany, Helmut Butzkueven, Cavit Boz, Valentina Tomassini, Matteo Foschi, José Luis Sánchez-Menoyo, Ayse Altintas, Saloua Mrabet, Gerardo Iuliano, Maria Jose Sa, Raed Alroughani, Rana Karabudak, Eduardo Aguera-Morales, Orla Gray, Koen de Gans, Anneke van der Walt, Pamela A McCombe, Norma Deri, Justin Garber, Abdullah Al-Asmi, Olga Skibina, Pierre Duquette, Elisabetta Cartechini, Daniele Spitaleri, Riadh Gouider, Aysun Soysal, Liesbeth Van Hijfte, Mark Slee, Maria Pia Amato, Katherine Buzzard, Guy Laureys
J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1021-1031. doi: 10.1136/jnnp-2023-333307.

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sifat Sharmin, Izanne Roos, Charles B Malpas, Pietro Iaffaldano, Marta Simone, Massimo Filippi, Eva Kubala Havrdova, Serkan Ozakbas, Vincenzo Brescia Morra, Raed Alroughani, Mauro Zaffaroni, Francesco Patti, Sara Eichau, Giuseppe Salemi, Alessia Di Sapio, Matilde Inglese, Emilio Portaccio, Maria Trojano, Maria Pia Amato, Tomas Kalincik, Writing Group, Italian Multiple Sclerosis and Related Disorders Register and MSBase Study Group
Lancet Child Adolesc Health. 2024 May;8(5):348-357. doi: 10.1016/S2352-4642(24)00047-6. Epub 2024 Mar 25.

Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Jennifer Massey, Ian Sutton, Barbara Withers, Mark S Freedman, Harold Atkins, Eva Krasulova, Eva Kubala Havrdova, Marek Trneny, Tomas Kozak, Joachim Burman, Richard Macdonell, Øivind Torkildsen, Lars Bø, Anne Kristine Lehmann, Basil Sharrack, John Snowden
J Neurol Neurosurg Psychiatry. 2024 Jul 15;95(8):775-783. doi: 10.1136/jnnp-2023-332790.

Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Katherine Buzzard, Michael Zhong, Wei Zhen Yeh, Vilija Jokubaitis, Mastura Monif, Olga Skibina, Serkan Ozakbas, Francesco Patti, Pierre Grammond, Maria Pia Amato, Tomas Kalincik, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Jeanette Lechner Scott, Cavit Boz, Maria Jose Sa, Helmut Butzkueven, Anneke van der Walt, Chao Zhu, MSBASE study group
J Neurol Neurosurg Psychiatry. 2024 Jul 15;95(8):767-774. doi: 10.1136/jnnp-2023-332883.

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman, MSBase Investigators
Ther Adv Neurol Disord. 2024 Feb 26;17:17562864231221331. doi: 10.1177/17562864231221331. eCollection 2024.

Language impairments in seropositive and seronegative autoimmune encephalitis
Sarah P Griffith, Robb Wesselingh, Fiore D'Aprano, Nabil Seery, Tiffany Rushen, Chris Kyndt, Brian Long, Udaya Seneviratne, Tomas Kalincik, Katherine Buzzard, Helmut Butzkueven, Terence J O'Brien, Rubina Alpitsis, Charles B Malpas, Mastura Monif, Australian Autoimmune Encephalitis Consortium
Neurol Sci. 2024 Jul;45(7):3389-3398. doi: 10.1007/s10072-024-07382-2. Epub 2024 Feb 15.

Sample Entropy Improves Assessment of Postural Control in Early-Stage Multiple Sclerosis
L Eduardo Cofré Lizama, Xiangyu He, Tomas Kalincik, Mary P Galea, Maya G Panisset
Sensors (Basel). 2024 Jan 29;24(3):872. doi: 10.3390/s24030872.

Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies
Francesca Bridge, Julia Brotherton, Jim Stankovich, Paul G Sanfilippo, Olga G Skibina, Katherine Buzzard, Tomas Kalincik, Ai-Lan Nguyen, Kylie Guo, Mastura Monif, C David Wrede, Louise Rath, Lisa Taylor, Helmut Butzkueven, Vilija G Jokubaitis, Anneke Van Der Walt
Neurology. 2024 Feb;102(4):e208059. doi: 10.1212/WNL.0000000000208059. Epub 2024 Feb 2.

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, Jane Andersen, Fiona Tea, Vera Merheb, Kristy Nguyen, Fiona X Z Lee, Marzena J Fabis-Pedrini, Alicia Zou, Ali Buckland, Anthony Fok, Michael H Barnett, Stephen W Reddel, Romain Marignier, Aseel El Hajj, Mastura Monif, Anneke van der Walt, Jeannette Lechner-Scott, Allan G Kermode, Tomas Kalincik, Simon A Broadley, Russell C Dale, Sudarshini Ramanathan, Fabienne Brilot, on behalf the Australasian MOGAD Study Group
J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):544-553. doi: 10.1136/jnnp-2023-332851.

Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry
Alessio Signori, Marta Ponzano, Tomas Kalincik, Serkan Ozakbas, Dana Horakova, Eva Kubala Havrdova, Raed Alroughani, Francesco Patti, Jens Kuhle, Guillermo Izquierdo, Sara Eichau, Bassem Yamout, Samia Joseph Khoury, Rana Karabudak, Pierre Grammond, Pierre Duquette, Izanne Roos, Helmut Butzkueven, Anneke van der Walt, Maria Pia Sormani
J Neurol Neurosurg Psychiatry. 2024 Jun 17;95(7):620-625. doi: 10.1136/jnnp-2023-332603.

Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Tim Spelman, Melinda Magyari, Helmut Butzkueven, Anneke Van Der Walt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Henrik Mathiesen, Jan Hillert, Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Front Neurol. 2023 Dec 22;14:1274194. doi: 10.3389/fneur.2023.1274194. eCollection 2023.

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
T Spelman, W L Herring, C Acosta, R Hyde, V G Jokubaitis, E Pucci, A Lugaresi, G Laureys, E K Havrdova, D Horakova, G Izquierdo, S Eichau, S Ozakbas, R Alroughani, T Kalincik, P Duquette, M Girard, T Petersen, F Patti, T Csepany, F Granella, F Grand'Maison, D Ferraro, R Karabudak, M Jose Sa, M Trojano, V van Pesch, B Van Wijmeersch, E Cartechini, P McCombe, O Gerlach, D Spitaleri, C Rozsa, S Hodgkinson, R Bergamaschi, R Gouider, A Soysal, None Castillo-Triviño, J Prevost, J Garber, K de Gans, R Ampapa, M Simo, J L Sanchez-Menoyo, G Iuliano, A Sas, A van der Walt, N John, O Gray, S Hughes, G De Luca, M Onofrj, K Buzzard, O Skibina, M Terzi, M Slee, C Solaro, None Oreja-Guevara, C Ramo-Tello, Y Fragoso, V Shaygannejad, F Moore, C Rajda, E Aguera Morales, H Butzkueven
J Med Econ. 2024 Jan-Dec;27(1):109-125. doi: 10.1080/13696998.2023.2293379. Epub 2023 Dec 26.

Patterns of neurotoxicity among patients receiving chimeric antigen receptor T-cell therapy: A single-centre cohort study
Carmela Sales, Mary Ann Anderson, Valeriya Kuznetsova, Hannah Rosenfeld, Charles B Malpas, Izanne Roos, Michael Dickinson, Simon Harrison, Tomas Kalincik
Eur J Neurol. 2024 Mar;31(3):e16174. doi: 10.1111/ene.16174. Epub 2023 Dec 12.

Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
Helmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, Robyn M Lucas, Deborah Mason, Simon Broadley, Trevor Kilpatrick, Jeannette Lechner-Scott, Michael Barnett, William Carroll, Peter Mitchell, Todd A Hardy, Richard Macdonell, Pamela McCombe, Andrew Lee, Tomas Kalincik, Anneke van der Walt, Chris Lynch, David Abernethy, Ernest Willoughby, Frederik Barkhof, David MacManus, Michael Clarke, Julie Andrew, Julia Morahan, Chao Zhu, Keith Dear, Bruce V Taylor, PREVANZ Investigators
Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409.

How effective is effective enough?
Tomas Kalincik, Amy Brodtmann
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):1. doi: 10.1136/jnnp-2023-332311.

Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience-Reply
Izanne Roos, Tomas Kalincik
JAMA Neurol. 2024 Jan 1;81(1):87-88. doi: 10.1001/jamaneurol.2023.4392.

Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Albert Aboseif, Izanne Roos, Stephen Krieger, Tomas Kalincik, Carrie M Hersh
Neurol Clin. 2024 Feb;42(1):203-227. doi: 10.1016/j.ncl.2023.06.003. Epub 2023 Jul 21.

Methodological considerations for observational studies of treatment effectiveness in neurology: a clinician's guide
Tomas Kalincik, Izanne Roos, Sifat Sharmin, Charles B Malpas
J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):454-460. doi: 10.1136/jnnp-2022-330038.

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Ying Li, Alice Saul, Bruce Taylor, Anne-Louise Ponsonby, Steve Simpson-Yap, Leigh Blizzard, Simon Broadley, Jeannette Lechner-Scott, Ausimmune/AusLong Investigators Group, Rana Karabudak, Francesco Patti, Sara Eichau, Marco Onofrj, Serkan Ozakbas, Dana Horakova, Eva Kubala Havrdova, Francois Grand'Maison, Raed Alroughani, Oliver Gerlach, Maria Pia Amato, Ayse Altintas, Marc Girard, Pierre Duquette, Yolanda Blanco, Cristina Ramo-Tello, Guy Laureys, Tomas Kalincik, Samia J Khoury, Vahid Shaygannejad, Masoud Etemadifar, Bhim Singhal, Saloua Mrabet, Matteo Foschi, Mario Habek, Nevin John, Stella Hughes, Pamela McCombe, Radek Ampapa, Anneke van der Walt, Helmut Butzkueven, Koen de Gans, Chris McGuigan, Celia Oreja-Guevara, Maria Jose Sa, Thor Petersen, Talal Al-Harbi, Angel Perez Sempere, Bart Van Wijmeersch, Nikolaos Grigoriadis, Julie Prevost, Orla Gray, Tamara Castillo-Triviño, Richard Macdonell, Alessandra Lugaresi, Seyed Aidin Sajedi, MSBase, Ingrid van der Mei
J Neurol. 2024 Jan;271(1):472-485. doi: 10.1007/s00415-023-11980-z. Epub 2023 Sep 28.

Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns
Chris Dwyer, Sifat Sharmin, Tomas Kalincik
Eur J Neurol. 2024 Jan;31(1):e16059. doi: 10.1111/ene.16059. Epub 2023 Sep 14.

Observational studies of treatment effectiveness in neurology
Tomas Kalincik, Izanne Roos, Sifat Sharmin
Brain. 2023 Dec 1;146(12):4799-4808. doi: 10.1093/brain/awad278.

The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, Chao Zhu, Katherine Buzzard, Jeannette Lechner-Scott, Michael Barnett, Bruce Taylor, Tomas Kalincik, Trevor Kilpatrick, David Darby, Pamela Dobay, Johan van Beek, Robert Hyde, Helmut Butzkueven, Anneke van der Walt
Eur J Neurol. 2024 Jan;31(1):e16046. doi: 10.1111/ene.16046. Epub 2023 Aug 24.

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders
Dhamidhu Eratne, Matthew Kang, Charles Malpas, Steve Simpson-Yap, Courtney Lewis, Christa Dang, Jasleen Grewal, Amy Coe, Hannah Dobson, Michael Keem, Wei-Hsuan Chiu, Tomas Kalincik, Suyi Ooi, David Darby, Amy Brodtmann, Oskar Hansson, Shorena Janelidze, Kaj Blennow, Henrik Zetterberg, Adam Walker, Olivia Dean, Michael Berk, Cassandra Wannan, Christos Pantelis, Samantha M Loi, Mark Walterfang, Samuel F Berkovic, Alexander F Santillo, Dennis Velakoulis
Aust N Z J Psychiatry. 2024 Jan;58(1):70-81. doi: 10.1177/00048674231187312. Epub 2023 Jul 21.

Early Treatment for Multiple Sclerosis: Time Is Brain
Erin E Longbrake, Tomas Kalincik
Neurology. 2023 Sep 26;101(13):549-550. doi: 10.1212/WNL.0000000000207754. Epub 2023 Jul 19.

Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022
Steve Simpson-Yap, Duncan Maddox, Jeanette Reece, Jeannette Lechner-Scott, Cameron Shaw, Bruce Taylor, Tomas Kalincik, Anneke van der Walt, Mike Boggild
Mult Scler Relat Disord. 2023 Sep;77:104845. doi: 10.1016/j.msard.2023.104845. Epub 2023 Jun 28.

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Mark S Freedman, Harold Atkins, Joachim Burman, Jennifer Massey, Ian Sutton, Barbara Withers, Richard Macdonell, Andrew Grigg, Øivind Torkildsen, Lars Bo, Anne Kristine Lehmann, Eva Kubala Havrdova, Eva Krasulova, Marek Trnený, Tomas Kozak, Anneke van der Walt, Helmut Butzkueven, Pamela McCombe, Olga Skibina, Jeannette Lechner-Scott, Barbara Willekens, Elisabetta Cartechini, Serkan Ozakbas, Raed Alroughani, Jens Kuhle, Francesco Patti, Pierre Duquette, Alessandra Lugaresi, Samia J Khoury, Mark Slee, Recai Turkoglu, Suzanne Hodgkinson, Nevin John, Davide Maimone, Maria Jose Sa, Vincent van Pesch, Oliver Gerlach, Guy Laureys, Liesbeth Van Hijfte, Rana Karabudak, Daniele Spitaleri, Tunde Csepany, Riadh Gouider, Tamara Castillo-Triviño, Bruce Taylor, Basil Sharrack, John A Snowden, MSBase Study Group Collaborators, MSBase Study Group Authors, Saloua Mrabet, Justin Garber, Jose Luis Sanchez-Menoyo, Eduardo Aguera-Morales, Yolanda Blanco, Abdullah Al-Asmi, Bianca Weinstock-Guttman, Yara Fragoso, Koen de Gans, Allan Kermode, MSBase Study Group
JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/jamaneurol.2023.1184.

Risk of secondary progressive multiple sclerosis after early worsening of disability
Winston Dzau, Sifat Sharmin, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Serkan Ozakbas, Oliver Gerlach, Cavit Boz, Pierre Grammond, Murat Terzi, Maria Pia Amato, Daniele La Spitaleri, Cristina Ramo-Tello, Davide Maimone, Elisabetta Cartechini, Katherine Buzzard, Olga Skibina, Anneke van der Walt, Helmut Butzkueven, Gerardo Iuliano, Aysun Soysal, Tomas Kalincik
J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):984-991. doi: 10.1136/jnnp-2023-331748. Epub 2023 Jul 6.

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
Ibrahima Diouf, Charles B Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Pierre Grammond, Bassem Yamout, Ayse Altintas, Oliver Gerlach, Jeannette Lechner-Scott, Roberto Bergamaschi, Rana Karabudak, Gerardo Iuliano, Christopher McGuigan, Elisabetta Cartechini, Stella Hughes, Maria Jose Sa, Claudio Solaro, Ludwig Kappos, Suzanne Hodgkinson, Mark Slee, Franco Granella, Koen de Gans, Pamela A McCombe, Radek Ampapa, Anneke van der Walt, Helmut Butzkueven, José Luis Sánchez-Menoyo, Steve Vucic, Guy Laureys, Youssef Sidhom, Riadh Gouider, Tamara Castillo-Trivino, Orla Gray, Eduardo Aguera-Morales, Abdullah Al-Asmi, Cameron Shaw, Talal M Al-Harbi, Tunde Csepany, Angel P Sempere, Irene Treviño Frenk, Elizabeth A Stuart, Tomas Kalincik
J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):1004-1011. doi: 10.1136/jnnp-2023-331499. Epub 2023 Jul 6.

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Serkan Ozakbas, Dana Horakova, Eva K Havrdova, Francesco Patti, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Cavit Boz, Magd Zakaria, Marco Onofrj, Alessandra Lugaresi, Bianca Weinstock-Guttman, Alexandre Prat, Marc Girard, Pierre Duquette, Murat Terzi, Maria Pia Amato, Rana Karabudak, Francois Grand'Maison, Samia J Khoury, Pierre Grammond, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Anneke van der Walt, Helmut Butzkueven, Recai Turkoglu, Ayse Altintas, Davide Maimone, Allan Kermode, Nevin Shalaby, Vincent V Pesch, Ernest Butler, Youssef Sidhom, Riadh Gouider, Saloua Mrabet, Oliver Gerlach, Aysun Soysal, Michael Barnett, Jens Kuhle, Stella Hughes, Maria J Sa, Suzanne Hodgkinson, Celia Oreja-Guevara, Radek Ampapa, Thor Petersen, Cristina Ramo-Tello, Daniele Spitaleri, Pamela McCombe, Bruce Taylor, Julie Prevost, Matteo Foschi, Mark Slee, Chris McGuigan, Guy Laureys, Liesbeth V Hijfte, Koen de Gans, Claudio Solaro, Jiwon Oh, Richard Macdonell, Eduardo Aguera-Morales, Bhim Singhal, Orla Gray, Justin Garber, Bart V Wijmeersch, Mihaela Simu, Tamara Castillo-Triviño, Jose L Sanchez-Menoyo, Dheeraj Khurana, Abdullah Al-Asmi, Talal Al-Harbi, Norma Deri, Yara Fragoso, Patrice H Lalive, L G F Sinnige, Cameron Shaw, Neil Shuey, Tunde Csepany, Angel P Sempere, Fraser Moore, Danny Decoo, Barbara Willekens, Claudio Gobbi, Jennifer Massey, Todd Hardy, John Parratt, Tomas Kalincik
Brain. 2023 Nov 2;146(11):4633-4644. doi: 10.1093/brain/awad218.

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, Anneke van der Walt, Helmut Butzkueven, Jeannette Lechner-Scott, Jens Kuhle, Murat Terzi, Guy Laureys, Liesbeth Van Hijfte, Nevin John, Pierre Grammond, Francois Grand'Maison, Aysun Soysal, Ana Voldsgaard Jensen, Peter Vestergaard Rasmussen, Kristina Bacher Svendsen, Ismael Barzinji, Helle Hvilsted Nielsen, Tobias Sejbæk, Sivagini Prakash, Morten Leif Munding Stilund, Arkadiusz Weglewski, Nadia Mubder Issa, Matthias Kant, Finn Sellebjerg, Orla Gray, Melinda Magyari, Tomas Kalincik, MSBase Study GroupDanish MS Registry Study Group
JAMA Neurol. 2023 Aug 1;80(8):789-797. doi: 10.1001/jamaneurol.2023.1625.

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, Murat Terzi, Suzanne Hodgkinson, Guy Laureys, Tomas Kalincik, Anneke Van Der Walt, Bassem Yamout, Jeannette Lechner-Scott, Aysun Soysal, Jens Kuhle, Jose Luis Sanchez-Menoyo, Yolanda Blanco Morgado, Daniele LA Spitaleri, Vincent van Pesch, Dana Horakova, Radek Ampapa, Francesco Patti, Richard Macdonell, Abdullah Al-Asmi, Oliver Gerlach, Jiwon Oh, Ayse Altintas, Namita Tundia, Schiffon L Wong, Helmut Butzkueven, MSBase Study Group
Neurodegener Dis Manag. 2023 Aug;13(4):215-221. doi: 10.2217/nmt-2023-0005. Epub 2023 Jun 7.

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation
Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, Francesco Patti, Francois Grand'Maison, Suzanne Hodgkinson, Pierre Grammond, Jeannette Lechner-Scott, Ernest Butler, Alexandre Prat, Marc Girard, Pierre Duquette, Richard A L Macdonell, Bianca Weinstock-Guttman, Serkan Ozakbas, Mark Slee, Maria Jose Sa, Vincent Van Pesch, Michael Barnett, Bart Van Wijmeersch, Oliver Gerlach, Julie Prevost, Murat Terzi, Cavit Boz, Guy Laureys, Liesbeth Van Hijfte, Allan G Kermode, Justin Garber, Bassem Yamout, Samia J Khoury, Daniel Merlo, Mastura Monif, Vilija Jokubaitis, Anneke van der Walt, Helmut Butzkueven, MSBase Study Group
JAMA Neurol. 2023 Jul 1;80(7):739-748. doi: 10.1001/jamaneurol.2023.1542.

Modelling accessibility of adult neurology care in Australia, 2020-2034
Steve Simpson-Yap, Federico Frascoli, Lucinda Harrison, Charles Malpas, James Burrell, Nicholas Child, Lauren P Giles, Christian Lueck, Merrilee Needham, Benjamin Tsang, Tomas Kalincik
BMJ Neurol Open. 2023 Apr 27;5(1):e000407. doi: 10.1136/bmjno-2023-000407. eCollection 2023.

Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders
Matthew J Y Kang, Dhamidhu Eratne, Hannah Dobson, Charles B Malpas, Michael Keem, Courtney Lewis, Jasleen Grewal, Vivian Tsoukra, Christa Dang, Ramon Mocellin, Tomas Kalincik, Alexander F Santillo, Henrik Zetterberg, Kaj Blennow, Christiane Stehmann, Shiji Varghese, Qiao-Xin Li, Colin L Masters, Steven Collins, Samuel F Berkovic, Andrew Evans, Wendy Kelso, Sarah Farrand, Samantha M Loi, Mark Walterfang, Dennis Velakoulis
Acta Neuropsychiatr. 2024 Feb;36(1):17-28. doi: 10.1017/neu.2023.25. Epub 2023 Apr 28.

Disability accrual in primary and secondary progressive multiple sclerosis
Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, Charles B Malpas, Ibrahima Diouf, Nahid Moradi, Sifat Sharmin, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Dana Horakova, Eva Kubala Havrdova, Alexandre Prat, Marc Girard, Pierre Duquette, Francois Grand'Maison, Marco Onofrj, Alessandra Lugaresi, Pierre Grammond, Serkan Ozakbas, Maria Pia Amato, Oliver Gerlach, Patrizia Sola, Diana Ferraro, Katherine Buzzard, Olga Skibina, Jeannette Lechner-Scott, Raed Alroughani, Cavit Boz, Vincent Van Pesch, Elisabetta Cartechini, Murat Terzi, Davide Maimone, Cristina Ramo-Tello, Bassem Yamout, Samia Joseph Khoury, Daniele La Spitaleri, Maria Jose Sa, Yolanda Blanco, Franco Granella, Mark Slee, Ernest Butler, Youssef Sidhom, Riadh Gouider, Roberto Bergamaschi, Rana Karabudak, Radek Ampapa, José Luis Sánchez-Menoyo, Julie Prevost, Tamara Castillo-Trivino, Pamela A McCombe, Richard Macdonell, Guy Laureys, Liesbeth Van Hijfte, Jiwon Oh, Ayse Altintas, Koen de Gans, Recai Turkoglu, Anneke van der Walt, Helmut Butzkueven, Steve Vucic, Michael Barnett, Edgardo Cristiano, Suzanne Hodgkinson, Gerardo Iuliano, Ludwig Kappos, Jens Kuhle, Vahid Shaygannejad, Aysun Soysal, Bianca Weinstock-Guttman, Bart Van Wijmeersch, Tomas Kalincik, MSBase investigators
J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):707-717. doi: 10.1136/jnnp-2022-330726. Epub 2023 Apr 17.

Optimal sensor location and direction to accurately classify people with early-stage multiple sclerosis using gait stability
L Eduardo Cofré Lizama, Maya G Panisset, Liuhua Peng, Ying Tan, Tomas Kalincik, Mary P Galea
Gait Posture. 2023 May;102:39-42. doi: 10.1016/j.gaitpost.2023.02.009. Epub 2023 Feb 23.

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Cyrus Daruwalla, Vahid Shaygannejad, Serkan Ozakbas, Eva Kubala Havrdova, Dana Horakova, Raed Alroughani, Cavit Boz, Francesco Patti, Marco Onofrj, Alessandra Lugaresi, Sara Eichau, Marc Girard, Alexandre Prat, Pierre Duquette, Bassem Yamout, Samia J Khoury, Seyed Aidin Sajedi, Recai Turkoglu, Ayse Altintas, Olga Skibina, Katherine Buzzard, Pierre Grammond, Rana Karabudak, Anneke van der Walt, Helmut Butzkueven, Davide Maimone, Jeannette Lechner-Scott, Aysun Soysal, Nevin John, Julie Prevost, Daniele Spitaleri, Cristina Ramo-Tello, Oliver Gerlach, Gerardo Iuliano, Matteo Foschi, Radek Ampapa, Vincent van Pesch, Michael Barnett, Nevin Shalaby, Marie D'hooghe, Jens Kuhle, Maria Jose Sa, Marzena Fabis-Pedrini, Allan Kermode, Saloua Mrabet, Riadh Gouider, Suzanne Hodgkinson, Guy Laureys, Liesbeth Van Hijfte, Richard Macdonell, Celia Oreja-Guevara, Edgardo Cristiano, Pamela McCombe, Jose Luis Sanchez-Menoyo, Bhim Singhal, Yolanda Blanco, Stella Hughes, Justin Garber, Claudio Solaro, Chris McGuigan, Bruce Taylor, Koen de Gans, Mario Habek, Abdullah Al-Asmi, Simu Mihaela, Tamara Castillo Triviño, Talal Al-Harbi, Juan Ignacio Rojas, Orla Gray, Dheeraj Khurana, Bart Van Wijmeersch, Nikolaos Grigoriadis, Jihad Inshasi, Jiwon Oh, Eduardo Aguera-Morales, Yara Fragoso, Fraser Moore, Cameron Shaw, Seyed Mohammad Baghbanian, Neil Shuey, Barbara Willekens, Todd A Hardy, Danny Decoo, Angel Perez Sempere, Deborah Field, Ray Wynford-Thomas, Nick G Cunniffe, Izanne Roos, Charles B Malpas, Alasdair J Coles, Tomas Kalincik, J William L Brown
Mult Scler. 2023 Jun;29(7):875-883. doi: 10.1177/13524585231151951. Epub 2023 Feb 27.

Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis
Yew Li Dang, Vivien Ty Yong, Sifat Sharmin, Piero Perucca, Tomas Kalincik
Mult Scler. 2023 May;29(6):657-667. doi: 10.1177/13524585231151400. Epub 2023 Feb 19.

Comparative effectiveness in multiple sclerosis: A methodological comparison
Izanne Roos, Ibrahima Diouf, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Pierre Grammond, Recai Turkoglu, Katherine Buzzard, Olga Skibina, Bassem Yamou, Ayse Altintas, Oliver Gerlach, Vincent van Pesch, Yolanda Blanco, Davide Maimone, Jeannette Lechner-Scott, Roberto Bergamaschi, Rana Karabudak, Chris McGuigan, Elisabetta Cartechini, Michael Barnett, Stella Hughes, Maria José Sa, Claudio Solaro, Cristina Ramo-Tello, Suzanne Hodgkinson, Daniele Spitaleri, Aysun Soysal, Thor Petersen, Franco Granella, Koen de Gans, Pamela McCombe, Radek Ampapa, Bart Van Wijmeersch, Anneke van der Walt, Helmut Butzkueven, Julie Prevost, Jose Luis Sanchez-Menoyo, Guy Laureys, Riadh Gouider, Tamara Castillo-Triviño, Orla Gray, Eduardo Aguera-Morales, Abdullah Al-Asmi, Cameron Shaw, Norma Deri, Talal Al-Harbi, Yara Fragoso, Tunde Csepany, Angel Perez Sempere, Irene Trevino-Frenk, Jan Schepel, Fraser Moore, Charles Malpas, Tomas Kalincik
Mult Scler. 2023 Mar;29(3):326-332. doi: 10.1177/13524585231151394. Epub 2023 Feb 19.

Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity
Tim Spelman, Dana Horakova, Serkan Ozakbas, Raed Alroughani, Marco Onofrj, Tomas Kalincik, Alexandre Prat, Murat Terzi, Pierre Grammond, Francesco Patti, Tunde Csepany, Cavit Boz, Jeannette Lechner-Scott, Franco Granella, Francois Grand'Maison, Anneke van der Walt, Chao Zhu, Helmut Butzkueven, MSBase Study Group
Mult Scler Relat Disord. 2023 Feb;70:104477. doi: 10.1016/j.msard.2022.104477. Epub 2022 Dec 23.

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
Ibrahima Diouf, Charles B Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Sherif Hamdy, Patrizia Sola, Diana Ferraro, Pierre Grammond, Recai Turkoglu, Katherine Buzzard, Olga Skibina, Bassem Yamout, Ayse Altintas, Oliver Gerlach, Vincent van Pesch, Yolanda Blanco, Davide Maimone, Jeannette Lechner-Scott, Roberto Bergamaschi, Rana Karabudak, Gerardo Iuliano, Chris McGuigan, Elisabetta Cartechini, Michael Barnett, Stella Hughes, Maria José Sa, Claudio Solaro, Ludwig Kappos, Cristina Ramo-Tello, Edgardo Cristiano, Suzanne Hodgkinson, Daniele Spitaleri, Aysun Soysal, Thor Petersen, Mark Slee, Ernest Butler, Franco Granella, Koen de Gans, Pamela McCombe, Radek Ampapa, Bart Van Wijmeersch, Anneke van der Walt, Helmut Butzkueven, Julie Prevost, L G F Sinnige, Jose Luis Sanchez-Menoyo, Steve Vucic, Guy Laureys, Liesbeth Van Hijfte, Dheeraj Khurana, Richard Macdonell, Riadh Gouider, Tamara Castillo-Triviño, Orla Gray, Eduardo Aguera-Morales, Abdullah Al-Asmi, Cameron Shaw, Norma Deri, Talal Al-Harbi, Yara Fragoso, Tunde Csepany, Angel Perez Sempere, Irene Trevino-Frenk, Jan Schepel, Fraser Moore, Tomas Kalincik
Eur J Neurol. 2023 Apr;30(4):1014-1024. doi: 10.1111/ene.15706. Epub 2023 Feb 16.

Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis
James Broadley, Robb Wesselingh, Paul Beech, Udaya Seneviratne, Chris Kyndt, Katherine Buzzard, Cassie Nesbitt, Wendyl D'Souza, Amy Brodtmann, Richard Macdonell, Tomas Kalincik, Terence J O'Brien, Helmut Butzkueven, Mastura Monif, Australian Autoimmune Encephalitis Consortium
Neurol Sci. 2023 Apr;44(4):1327-1340. doi: 10.1007/s10072-022-06523-9. Epub 2022 Dec 8.

External validation of a clinical prediction model in multiple sclerosis
Nahid Moradi, Sifat Sharmin, Charles B Malpas, Vahid Shaygannejad, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Recai Turkoglu, Rana Karabudak, Nevin Shalaby, Aysun Soysal, Ayşe Altıntaş, Jihad Inshasi, Talal Al-Harbi, Raed Alroughani, Tomas Kalincik
Mult Scler. 2023 Feb;29(2):261-269. doi: 10.1177/13524585221136036. Epub 2022 Nov 30.

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity
Vilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, Jim Stankovich, Pavlina Kleinova, Fuencisla Matesanz, Daniel Hui, Sara Eichau, Mark Slee, Jeannette Lechner-Scott, Rodney Lea, Trevor J Kilpatrick, Tomas Kalincik, Philip L De Jager, Ashley Beecham, Jacob L McCauley, Bruce V Taylor, Steve Vucic, Louise Laverick, Karolina Vodehnalova, Maria-Isabel García-Sanchéz, Antonio Alcina, Anneke van der Walt, Eva Kubala Havrdova, Guillermo Izquierdo, Nikolaos Patsopoulos, Dana Horakova, Helmut Butzkueven
Brain. 2023 Jun 1;146(6):2316-2331. doi: 10.1093/brain/awac449.

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, Murat Terzi, Suzanne Hodgkinson, Guy Laureys, Tomas Kalincik, Anneke Van Der Walt, Bassem Yamout, Jeannette Lechner-Scott, Aysun Soysal, Jens Kuhle, Jose Luis Sanchez-Menoyo, Yolanda Blanco Morgado, Daniele LA Spitaleri, Vincent van Pesch, Dana Horakova, Radek Ampapa, Francesco Patti, Richard Macdonell, Abdullah Al-Asmi, Oliver Gerlach, Jiwon Oh, Ayse Altintas, Namita Tundia, Schiffon L Wong, Helmut Butzkueven
Mult Scler. 2023 Feb;29(2):221-235. doi: 10.1177/13524585221137502. Epub 2022 Nov 26.

Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Chao Zhu, Zhen Zhou, Izanne Roos, Daniel Merlo, Tomas Kalincik, Serkan Ozakbas, Olga Skibina, Jens Kuhle, Suzanne Hodgkinson, Cavit Boz, Raed Alroughani, Jeannette Lechner-Scott, Michael Barnett, Guillermo Izquierdo, Alexandre Prat, Dana Horakova, Eva Kubala Havrdova, Richard Macdonell, Francesco Patti, Samia Joseph Khoury, Mark Slee, Rana Karabudak, Marco Onofrj, Vincent Van Pesch, Julie Prevost, Mastura Monif, Vilija Jokubaitis, Anneke van der Walt, Helmut Butzkueven, MSBase Study Group
J Neurol Neurosurg Psychiatry. 2022 Dec;93(12):1330-1337. doi: 10.1136/jnnp-2022-330104. Epub 2022 Oct 19.

Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, Ibrahima Diouf, Raed Alroughani, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Dana Horakova, Eva K Havrdova, Francesco Patti, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Marco Onofrj, Alessandra Lugaresi, Ayse Altintas, Alexandre Prat, Marc Girard, Pierre Duquette, Maria José Sá, Daniele La Spitaleri, Youssef Sidhom, Riadh Gouider, Saloua Mrabet, Aysun Soysal, Recai Turkoglu, Maria Pia Amato, Yara D Fragoso, Tomas Kalincik
J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329713. doi: 10.1136/jnnp-2022-329713. Online ahead of print.

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
Alessio Signori, Johannes Lorscheider, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Jan Hillert, Robert Hyde, Fabio Pellegrini, Melinda Magyari, Nils Koch-Henriksen, Per Soelberg Sørensen, Tim Spelman, Anneke van der Walt, Dana Horakova, Eva Havrdova, Marc Girard, Sara Eichau, Francois Grand'Maison, Oliver Gerlach, Murat Terzi, Serkan Ozakbas, Olga Skibina, Vincent Van Pesch, Maria Jose Sa, Julie Prevost, Raed Alroughani, Pamela A McCombe, Riadh Gouider, Saloua Mrabet, Tamara Castillo-Trivino, Chao Zhu, Koen de Gans, José Luis Sánchez-Menoyo, Bassem Yamout, Samia Khoury, Maria Pia Sormani, Tomas Kalincik, Helmut Butzkueven, Big MS Data Network
J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):23-30. doi: 10.1136/jnnp-2022-329987. Epub 2022 Sep 28.

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand
Suzi Claflin, Julie A Campbell, Richard Norman, Deborah F Mason, Tomas Kalincik, Steve Simpson-Yap, Helmut Butzkueven, William M Carroll, Andrew J Palmer, C Leigh Blizzard, Ingrid van der Mei, Glen J Henson, Bruce V Taylor
Eur J Health Econ. 2023 Aug;24(6):939-950. doi: 10.1007/s10198-022-01518-x. Epub 2022 Sep 23.

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
Belinda Cruse, Thanuja Dharmadasa, Elise White, Callum Hollis, Andrew Evans, Sifat Sharmin, Tomas Kalincik, Lynette Kiers
BMJ Neurol Open. 2022 Sep 5;4(2):e000328. doi: 10.1136/bmjno-2022-000328. eCollection 2022.

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Tina Parciak, Anne Helme, Nick Rijke, Jan A Hillert, Yves Moreau, Gilles Edan, Sifat Sharmin, Tim Spelman, Robert McBurney, Hollie Schmidt, Arnfin B Bergmann, Stefan Braune, Alexander Stahmann, Rod M Middleton, Amber Salter, Bruce Bebo, Anneke Van der Walt, Helmut Butzkueven, Serkan Ozakbas, Cavit Boz, Rana Karabudak, Raed Alroughani, Juan I Rojas, Ingrid A van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo N Alonso, Richard S Nicholas, Anibal S Chertcoff, Ana Zabalza de Torres, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Liesbet M Peeters
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 29;9(6):e200021. doi: 10.1212/NXI.0000000000200021. Print 2022 Nov.

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Charles Malpas, Emmanuelle Leray, Romain Casey, Dana Horakova, Eva Kubala Havrdova, Marc Debouverie, Francesco Patti, Jerome De Seze, Guillermo Izquierdo, Sara Eichau, Gilles Edan, Alexandre Prat, Marc Girard, Serkan Ozakbas, Pierre Grammond, Helene Zephir, Jonathan Ciron, Elisabeth Maillart, Thibault Moreau, Maria Pia Amato, Pierre Labauge, Raed Alroughani, Katherine Buzzard, Olga Skibina, Murat Terzi, David Axel Laplaud, Eric Berger, Francois Grand'Maison, Christine Lebrun-Frenay, Elisabetta Cartechini, Cavit Boz, Jeannette Lechner-Scott, Pierre Clavelou, Bruno Stankoff, Julie Prevost, Ludwig Kappos, Jean Pelletier, Vahid Shaygannejad, Bassem I Yamout, Samia J Khoury, Oliver Gerlach, Daniele L A Spitaleri, Vincent Van Pesch, Olivier Gout, Recai Turkoglu, Olivier Heinzlef, Eric Thouvenot, Pamela Ann McCombe, Aysun Soysal, Bertrand Bourre, Mark Slee, Tamara Castillo-Trivino, Serge Bakchine, Radek Ampapa, Ernest Gerard Butler, Abir Wahab, Richard A Macdonell, Eduardo Aguera-Morales, Philippe Cabre, Nasr Haifa Ben, Anneke Van der Walt, Guy Laureys, Liesbeth Van Hijfte, Cristina M Ramo-Tello, Nicolas Maubeuge, Suzanne Hodgkinson, José Luis Sánchez-Menoyo, Michael H Barnett, Celine Labeyrie, Steve Vucic, Youssef Sidhom, Riadh Gouider, Tunde Csepany, Javier Sotoca, Koen de Gans, Abdullah Al-Asmi, Yara Dadalti Fragoso, Sandra Vukusic, Helmut Butzkueven, Tomas Kalincik, MSBase and OFSEP
Neurology. 2022 Oct 25;99(17):e1926-e1944. doi: 10.1212/WNL.0000000000201029. Epub 2022 Aug 17.

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Steve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, Liesbet M Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik
Mult Scler Relat Disord. 2022 Oct;66:104072. doi: 10.1016/j.msard.2022.104072. Epub 2022 Jul 25.

Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis
Jing Chen, Ibrahima Diouf, Bruce V Taylor, Tomas Kalincik, Ingrid van der Mei
J Neurol Neurosurg Psychiatry. 2022 Jul 28:jnnp-2022-329223. doi: 10.1136/jnnp-2022-329223. Online ahead of print.

Prediction of relapse activity when switching to cladribine for multiple sclerosis
Michael Zhong, Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomas Kalincik, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prevost, Marc Girard, Jiwon Oh, Helmut Butzkueven, Vilija Jokubaitis
Mult Scler. 2023 Jan;29(1):119-129. doi: 10.1177/13524585221111677. Epub 2022 Jul 27.

Interrogating large multiple sclerosis registries and databases: what information can be gained?
Maria Trojano, Tomas Kalincik, Pietro Iaffaldano, Maria P Amato
Curr Opin Neurol. 2022 Jun 1;35(3):271-277. doi: 10.1097/WCO.0000000000001057.

Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
Vivien Li, Izanne Roos, Mastura Monif, Charles Malpas, Stefanie Roberts, Mark Marriott, Katherine Buzzard, Ai-Lan Nguyen, Nabil Seery, Lisa Taylor, Tomas Kalincik, Trevor Kilpatrick
Mult Scler Relat Disord. 2022 Jul;63:103913. doi: 10.1016/j.msard.2022.103913. Epub 2022 May 27.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
M Lefort, S Sharmin, J B Andersen, S Vukusic, R Casey, M Debouverie, G Edan, J Ciron, A Ruet, J De Sèze, E Maillart, H Zephir, P Labauge, G Defer, C Lebrun-Frenay, T Moreau, E Berger, P Clavelou, J Pelletier, B Stankoff, O Gout, E Thouvenot, O Heinzlef, A Al-Khedr, B Bourre, O Casez, P Cabre, A Montcuquet, A Wahab, J P Camdessanché, A Maurousset, H Ben Nasr, K Hankiewicz, C Pottier, N Maubeuge, D Dimitri-Boulos, C Nifle, D A Laplaud, D Horakova, E K Havrdova, R Alroughani, G Izquierdo, S Eichau, S Ozakbas, F Patti, M Onofrj, A Lugaresi, M Terzi, P Grammond, F Grand'Maison, B Yamout, A Prat, M Girard, P Duquette, C Boz, M Trojano, P McCombe, M Slee, J Lechner-Scott, R Turkoglu, P Sola, D Ferraro, F Granella, V Shaygannejad, J Prevost, D Maimone, O Skibina, K Buzzard, A Van der Walt, R Karabudak, B Van Wijmeersch, T Csepany, D Spitaleri, S Vucic, N Koch-Henriksen, F Sellebjerg, P S Soerensen, C C Hilt Christensen, P V Rasmussen, M B Jensen, J L Frederiksen, S Bramow, H K Mathiesen, K I Schreiber, H Butzkueven, M Magyari, T Kalincik, E Leray
BMC Med Res Methodol. 2022 May 30;22(1):155. doi: 10.1186/s12874-022-01623-8.

Confirmed disability progression as a marker of permanent disability in multiple sclerosis
Sifat Sharmin, Francesca Bovis, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Guillermo Izquierdo, Sara Eichau, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Murat Terzi, Oliver Gerlach, Raed Alroughani, Cavit Boz, Vahid Shaygannejad, Vincent van Pesch, Elisabetta Cartechini, Ludwig Kappos, Jeannette Lechner-Scott, Roberto Bergamaschi, Recai Turkoglu, Claudio Solaro, Gerardo Iuliano, Franco Granella, Bart Van Wijmeersch, Daniele Spitaleri, Mark Slee, Pamela McCombe, Julie Prevost, Radek Ampapa, Serkan Ozakbas, Jose Luis Sanchez-Menoyo, Aysun Soysal, Steve Vucic, Thor Petersen, Koen de Gans, Ernest Butler, Suzanne Hodgkinson, Youssef Sidhom, Riadh Gouider, Edgardo Cristiano, Tamara Castillo-Triviño, Maria Laura Saladino, Michael Barnett, Fraser Moore, Csilla Rozsa, Bassem Yamout, Olga Skibina, Anneke van der Walt, Katherine Buzzard, Orla Gray, Stella Hughes, Angel Perez Sempere, Bhim Singhal, Yara Fragoso, Cameron Shaw, Allan Kermode, Bruce Taylor, Magdolna Simo, Neil Shuey, Talal Al-Harbi, Richard Macdonell, Jose Andres Dominguez, Tunde Csepany, Carmen Adella Sirbu, Maria Pia Sormani, Helmut Butzkueven, Tomas Kalincik
Eur J Neurol. 2022 Aug;29(8):2321-2334. doi: 10.1111/ene.15406. Epub 2022 Jun 9.

Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy
Adam H Lapidus, Mary Ann Anderson, Simon J Harrison, Michael Dickinson, Tomas Kalincik, Arian Lasocki
Leuk Lymphoma. 2022 Oct;63(10):2364-2374. doi: 10.1080/10428194.2022.2074990. Epub 2022 May 14.

A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours
Joos Meyer, Ibrahima Diouf, James King, Kate Drummond, Stan Stylli, Andrew Kaye, Tomas Kalincik, Helen Danesh-Meyer, R C Andrew Symons
Pituitary. 2022 Aug;25(4):563-572. doi: 10.1007/s11102-022-01228-w. Epub 2022 May 13.

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study
Marianna Vitkova, Ibrahima Diouf, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Vahid Shaygannejad, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Catherine Larochelle, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Pierre Grammond, Helmut Butzkueven, Katherine Buzzard, Olga Skibina, Bassem I Yamout, Rana Karabudak, Oliver Gerlach, Jeannette Lechner-Scott, Davide Maimone, Roberto Bergamaschi, Vincent Van Pesch, Gerardo Iuliano, Elisabetta Cartechini, Maria José Sà, Radek Ampapa, Michael Barnett, Stella E Hughes, Cristina M Ramo-Tello, Suzanne Hodgkinson, Daniele L A Spitaleri, Thor Petersen, Ernest Gerard Butler, Mark Slee, Chris McGuigan, Pamela Ann McCombe, Franco Granella, Edgardo Cristiano, Julie Prevost, Bruce V Taylor, Josã Luis Sãnchez-Menoyo, Guy Laureys, Liesbeth Van Hijfte, Steve Vucic, Richard A Macdonell, Orla Gray, Javier Olascoaga, Norma Deri, Yara Dadalti Fragoso, Cameron Shaw, Tomas Kalincik, MSBase Study Group
Neurology. 2022 Jun 14;98(24):e2401-e2412. doi: 10.1212/WNL.0000000000200545. Epub 2022 Apr 11.